RSC Adv 5(128):106171106181
Oncol Rep 33(6):30613068 Almalki RS, Gazzaz M, Miski SF, Fayed HM, Mohamed B, Hessin AF et al (2025) Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosis
Pisoni, R
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy
Patients can start therapy within days rather than weeks, with transparent pricing, no insurance gatekeeping, and optional genetic testing through the Precision Peptide Genetic Test ($99 add-on after first month) to identify individual peptide-pathway optimization
Considering the close connection between metabolic dysfunction and MASLD, creating efficient prevention and treatment plans remains a top public health goal